Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Gabor Orban

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	8.2yrs
CEO ownership	n/a
Management average tenure	2.8yrs
Board average tenure	5.1yrs

Recent management updates

Recent updates

CEO

Gabor Orban (45 yo)

8.2yrs

Tenure

Mr. Gabor Orban has been Chief Executive Officer of Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. since November 1, 2017 and Member of Executive Board since September 05, 2016. Mr. Orban served as...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Gabor Orban	CEO, Member of Executive Board & Director	8.2yrs	no data	no data
Istvan Hamecz	CFO, Member of Executive Board & Director	2.8yrs	no data	no data
Istvan Greiner	R&D Director and Member of Executive Board	no data	no data	no data
Katalin Erdei	HR, Technical Director & Member of Executive Board	5.8yrs	no data	no data
Attila Szenasi	COO & Member of the Executive Board	2yrs	no data	no data
Tamas Szolyak	Commercial Director & Member of Executive Board	2yrs	no data	no data
Robert Rethy	Head of the Investor Relations & ESG Department	no data	no data	no data

2.8yrs

Average Tenure

53.5yo

Average Age

Experienced Management: RIG2's management team is considered experienced (2.8 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Gabor Orban	CEO, Member of Executive Board & Director	7.6yrs	no data	no data
Istvan Hamecz	CFO, Member of Executive Board & Director	2.6yrs	no data	no data
Erik Bogsch	Lifetime Honorary Chairman	32.8yrs	Ft6.24m	no data
Ilona dr Pinterne	Independent Deputy Chairman	7.6yrs	no data	no data
Balint Szecsenyi	Independent Director	6.6yrs	no data	no data
Szilveszter Vizi	Independent Chairman	16.8yrs	Ft6.24m	no data
Anett Pandurics	Independent Director	6.6yrs	no data	no data
Peter Cserhati	Independent Director	1.6yrs	no data	no data
Livia Pavlik	Chairman of the Supervisory Board	3.6yrs	no data	no data
Nandor Acs	Independent Director	3.6yrs	no data	no data
Gabriella Balogh	Independent Director	1.6yrs	no data	no data
Laszlone Nemeth	Independent Director	1.6yrs	no data	no data

5.1yrs

Average Tenure

56.5yo

Average Age

Experienced Board: RIG2's board of directors are considered experienced (5.1 years average tenure).

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt Management

Management criteria checks 2/4

Key information

Recent management updates

High number of new directors

High number of new directors

No independent directors

No independent directors

Recent updates

Third quarter 2024 earnings released: EPS: Ft203 (vs Ft294 in 3Q 2023)

Second quarter 2024 earnings released: EPS: Ft383 (vs Ft155 in 2Q 2023)

Upcoming dividend of Ft423 per share

High number of new directors

First quarter 2024 earnings released: EPS: Ft373 (vs Ft210 in 1Q 2023)

Dividend of Ft423 announced

High number of new directors

Full year 2023 earnings released: EPS: Ft860 (vs Ft907 in FY 2022)

Full year 2023 earnings released: EPS: Ft860 (vs Ft835 in FY 2022)

Third quarter 2023 earnings released: EPS: Ft294 (vs Ft442 in 3Q 2022)

European Commission Approves the Commercialisation of RYEQO® for the Symptomatic Treatment of Endometriosis

Gedeon Richter Plc., Sumitomo Pharma America, Inc. and Sumitomo Pharma Switzerland, GmbH Receives European Commission grant for Commercialisation of RYEQO®

Gedeon Richter and Sumitomo Pharma Receives Positive Chmp Opinion for Ryeqo(R) for Treatment of Endometriosis

Gedeon Richter and Sumitomo Pharma Receives Positive Chmp Opinion for Ryeqo(R) for Treatment of Endometriosis

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: Ft155 (vs Ft411 in 2Q 2022)

Upcoming dividend of Ft390 per share at 4.5% yield

First quarter 2023 earnings released: EPS: Ft210 (vs Ft199 in 1Q 2022)

Full year 2022 earnings released

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) acquired OC Distributors Ltd from Consilient Health for £32.5 million.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. to Report Q1, 2023 Results on May 12, 2023

No independent directors

Second quarter 2022 earnings released: EPS: Ft411 (vs Ft151 in 2Q 2021)

Upcoming dividend of Ft225 per share

Investor sentiment improved over the past week

No independent directors

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: EPS Ft205 (vs Ft121 in 3Q 2020)

Second quarter 2021 earnings released: EPS Ft151 (vs Ft170 in 2Q 2020)

Upcoming dividend of Ft225 per share

First quarter 2021 earnings released: EPS Ft145 (vs Ft156 in 1Q 2020)

New 90-day high: €24.26

Felicia Group agreed to acquire wholesale and retail operations from Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER).

New 90-day high: €21.42

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) completed the acquisition of Outside US Evra® transdermal contraceptive patch assets of Janssen Pharmaceutica NV.

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. to Report First Half, 2021 Results on Aug 03, 2021

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (BUSE:RICHTER) signed an asset purchase agreement to acquire Outside US Evra® transdermal contraceptive patch assets of Janssen Pharmaceutica NV for approximately $260 million.

New 90-day high: €20.34

New 90-day low: €17.66

Univfy Inc. and Gedeon Richter Announce Partnership to Launch Personalized in Vitro Fertilization Counselling Platform to Support Fertility Patients and Providers in Europe

New 90-day low - €17.51

CEO

Tenure

Leadership Team

Average Tenure

Average Age

Board Members

Average Tenure

Average Age